India's first coronavirus vaccine 'COVAXIN' human trials will begin on July 21 at the All India Institute of Medical Science (AIIMS), Delhi after its Ethics Committee gave its nod. COVAXIN is an indigenously developed COVID-19 vaccine. Watch report.

'Covaxin' human trial begins in AIIMS: Phase 1 & 2 trials of potential vaccine

covaxin-trial-at-aiims

Covaxin Trial At Aiims, News on Covaxin Trial At Aiims, stories on Covaxin Trial At Aiims, articles on Covaxin Trial At Aiims, Covaxin Trial At Aiims stories at Wion, Covaxin Trial At Aiims news, Covaxin Trial At Aiims latest news

covaxin trial-at-aiims

'Covaxin' human trial begins in AIIMS: Phase 1 & 2 trials of potential vaccine